نتایج جستجو برای: hematologic disease

تعداد نتایج: 1502143  

2008
J. DEPUE JOSEPH M. TUSCANO G. STEFANACCI

2018
Claudio Guarneri Uwe Wollina Torello Lotti Georgi Konstantinov Maximov Ilia Lozev Serena Gianfaldoni Ivan Pidakev Jacopo Lotti Georgi Tchernev

Firstly described by Robert Douglas Sweet in 1964, febrile neutrophilic dermatosis is a disabling, not only cutaneous disorder, clinically characterised by fever and painful erythematous nodules, with a typical background of neutrophilia. Sweet's syndrome (SS) is a chronic inflammatory reactive disorder of unknown cause and incompletely established pathogenesis, although an interplay between ge...

2017
María Herrero-Moyano Tania Marusia Capusan Alejandra Pérez-Plaza Almudena Godoy Javier Sánchez-Perez

AHNMD: associated clonal hematologic none mast cell lineage disease CM: cutaneous mastocytosis CMML: chronic myelomonocytic leukemia MPCM: maculopapular cutaneous mastocytosis SM: systemic mastocytosis INTRODUCTION Maculopapular cutaneous mastocytosis (MPCM) is the clinical variant of cutaneous mastocytosis (CM) most frequently observed in adults, usually within the context of an indolent syste...

2005
H. Teal

a Thalassemia modifies the hematologic expression of homozygous sickle cell (55) disease, resulting in increased total hemoglobin and HbA2 and decreased HbF. mean cell volume, reticulocytes. irreversibly sickled cells. and bilirubin levels. The age at which these changes develop in children with 55 disease is unknown. Ascertainment of globin gene status in a large representative sample of child...

Journal: :Haematologica 2006
Andrew Goringe Richard Ellis Ian McDowell Josep Vidal-Alaball Christopher Jenkins Christopher Butler Mark Worwood

Treatment of B12 deficiency is important to prevent progressive neurological and/or hematologic disease but requires a secure diagnosis. The aim of this study was to evaluate second line tests of B12 status as prognostic indicators of a hematologic response to vitamin B12 therapy. Forty-nine patients referred with low, serum vitamin B12 concentrations were treated with intramuscular B12 and re-...

2014
Pablo D. Garcia John L. Langowski Yingyun Wang Min Chen Joseph Castillo Christie Fanton Marjorie Ison Tatiana Zavorotinskaya Jing Lu Jamie Narberes Tiffany Tsang Christine Fritsch Audrey Kauffmann Estelle Pfister Peter Drueckes Joerg Trappe Christopher Wilson Wooseok Han Jiong Lan Gisele Nishiguchi Mika Lindvall Cornelia Bellamacina J. Alex Aycinena Richard Zang Matthew T. Burger

Purpose: PIMkinases have been shown to act as oncogenes inmice, with each familymember being able to drive progressionofhematologic cancers. Consistentwith this,we found that PIMs are highly expressed in human hematologic cancers and show that each isoform has a distinct expression pattern among disease subtypes. This suggests that inhibitors of all three PIMs would be effective in treating mul...

Journal: :Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG 2015
M J Overbeek A A van de Loosdrecht A Vonk-Noordegraaf

BACKGROUND A 29-year old patient presented with granulomatous lung disease and a family history of myelodysplastic syndrome/acute myeloid leukemia. She appeared to be a carrier of a mutation in the transcription factor GATA2. The case adds to the recent described heterogeneous clinical manifestations and syndromes in which, against a background of hematologic disorders, GATA2 mutations have bee...

بهادر, حبیب اله, قاسمی, شاهین,

In this Case report we presented an eighteen year old pregnant woman who suffered from intermittent fever, night sweat, weight loss and neck mass. she was referred to infectious disease clinic of the FIROOZABADI hospital and clinical and Labratory examinations revealed no hematologic, collagen vascular, malignant or infection diseases. However histopathologic biopsy of the neck lymph nodes reve...

2010
Sae Woong Kim Sung Dae Kim Je Mo Yoo Yong-Hyun Cho Dong Wan Sohn

PURPOSE We performed this study in order to evaluate the incidence and characteristics of urolithiasis in patients with malignant hematologic diseases. MATERIALS AND METHODS Nine hundred one patients who underwent medical treatment for malignant hematologic disease and 40,543 patients who visited the emergency room and without malignant hematologic diseases were included in our study. The pat...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید